|
KMID : 0980720090280010008
|
|
Keimyung Medical Journal
2009 Volume.28 No. 1 p.8 ~ p.16
|
|
|
Effect of Ezetimibe/Simvastatin and Atorvastatin with Conventional Dose on Achieving Target Low Density Lipoprotein Cholesterol Goal
|
|
Jun Dong-Hwan
Kim Kwon-Bae
Kim Hyung-Seop
Nam Chang-Wook
Han Seong-Wook
Hur Seung-Ho
Kim Yoon-Nyun
Kim Hyun-Tae
Kim In-Cheol
Cho Yun-Kyeong
|
|
|
Abstract
|
|
|
|
Although recent lipid-lowering agents were effective in reducing low-density lipoprotein (LDL) cholesterol level, many patients treated with lipid-lowering therapy did not achieve target LDL cholesterol level, especially in very high risk hypercholesterolemic patients. The aim of this study is to evaluate the efficacy of ezetimibe/simvastatin and atorvastatin with conventional dose on reducing lipid levels and achieving target LDL cholesterol level in very high risk hypercholesterolemic patients. A total of 79 patients in very high risk hypercholesterolemia were enrolled in the study. Patients are randomly grouped in 2: Group 1, ezetimibe/simvastatin 10/20 mg/day and Group 2, atorvastatin 10 mg/day. Target level of LDL cholesterol was defined less than <70 mg/dl at follow-up. The follow-up plasma lipid data were obtained after 8 weeks of treatment. Baseline plasma lipid data were similar between the two groups. Achieving target LDL cholesterol level was observed in 64% of the Group 1 and 40% of Group 2 at 8-week follow-up (p<0.05). Compared with Group 2, Group 1 showed a significantly reduction in LDL cholesterol and non-high density lipoprotein cholesterol and a trend toward to a greater reduction in total cholesterol and apolipoprotein A-1. In patients with very high risk hypercholesterolemia, ezetimibe/simvastatin 10/20 mg was superior to atorvastatin 10 mg/day in attainment of target LDL- cholesterol goal and in efficacy with other lipoprotein parameters.
|
|
|
KEYWORD
|
|
|
atorvastatin, ezetimibe, lipoprotein, simvastatin
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|